|Last Price$127.22||Day Change (%)-4.84%|
|Open Price$131.60||Day Change ($)-6.47|
|Day Range127.18–132.30||52-Week Range110.56–193.45|
As of Fri 9/23/2016 5:00:00 PM | USD
Alexion Employees Volunteer Together in Company’s First Global Day of Service
Alexion Launches Uncommon Strength Campaign to Unite and Celebrate the Courage and Resilience of People Living with Rare Diseases
Everbridge to Showcase Safety Connection™ and Growing Partner Ecosystem at ASIS 2016
Moderna Enters New Growth Phase with Closing of $474 Million Equity Financing and its First BARDA Grant for up to $125 Million for Zika mRNA Vaccine
Arterial Calcification Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Medestea Internazionale, Amgen, VitaK - Research and Markets
European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)
We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.
Standing out in a good year for stocks.
Ownership data provide a look at who else owns the company.
Buying a country or sector fund isn't as easy as it seems.